
FDA approves venglustat, the first oral therapy for Type 3 Gaucher neurological symptoms.
In the manufacture of many pharmaceutical products, dry-particle blending is a critical step that directly affects content uniformity.
over 21 years ago
How to Scale Up Scientificallyover 21 years ago
Scale Up of Liquid and Semisolid Manufacturing Processes




